United States Biotechnology & Medical Research

Protagenic Therapeutics Inc (PTIX)

Track

Track

Over the past 90 days, Protagenic Therapeutics Inc. recorded four insider trading transactions, all representing purchases by Executive Chair Garo H. Armen. These acquisitions totaled approximately $6,961. Despite a 44.6% decline in stock price during this period, no sales occurred. The company has not released a recent earnings report to provide further context.
Ticker: PTIX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Executive Director
Transaction date
Purchase
Price
311.96
Quantity 37,237 -19.0%
Value US$3,601,909
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Executive Director
Transaction date
Purchase
Price
431.66
Quantity 79,313 -45.3%
Value US$2,835,837
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Executive Director
Transaction date
Purchase
Price
448.41
Quantity 28,606 -15.3%
Value US$1,515,293
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF. Executive Director
Transaction date
Purchase
Price
0.18
Quantity 1,000 +inf%
Value US$100,000
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
0.81
Quantity 8,000 +21.2%
Value US$6,480
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
0.72
Quantity 8,000 +5.6%
Value US$5,760
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
0.71
Quantity 23,000 +19.1%
Value US$16,330
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
2.29
Quantity 1,000 +0.8%
Value US$2,290
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
2.29
Quantity 1,000 +0.8%
Value US$2,290
ARMEN GARO H See Remarks Executive Director Large shareholder
Transaction date
Purchase
Price
1.25
Quantity 60,211 +1.4%
Value US$75,264
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
2.09
Quantity 1,758 +0.4%
Value US$3,674
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
2.08
Quantity 300 +0.1%
Value US$624
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
2.07
Quantity 569 +0.1%
Value US$1,178
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
2.00
Quantity 74 +0.0%
Value US$148
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.99
Quantity 1,334 +0.3%
Value US$2,655
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.98
Quantity 900 +0.2%
Value US$1,782
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.97
Quantity 266 +0.1%
Value US$524
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.90
Quantity 5,000 +1.1%
Value US$9,500
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.79
Quantity 3,499 +0.8%
Value US$6,263
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.70
Quantity 100 +0.0%
Value US$170
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.64
Quantity 100 +0.0%
Value US$164
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.63
Quantity 600 +0.1%
Value US$978
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.60
Quantity 300 +0.1%
Value US$480
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.59
Quantity 200 +0.0%
Value US$318
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.60
Quantity 5,376 +0.2%
Value US$3,226
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.65
Quantity 527,683 +20.4%
Value US$342,888
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.67
Quantity 21,947 +0.9%
Value US$14,704
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.66
Quantity 86,386 +3.5%
Value US$56,989
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.85
Quantity 25,000 +1.0%
Value US$21,250
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.85
Quantity 50,500 +2.1%
Value US$42,925
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.86
Quantity 50,000 +2.1%
Value US$42,920
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.85
Quantity 11,100 +0.5%
Value US$9,435
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
1.17
Quantity 25,000 +1.1%
Value US$29,290
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.03
Quantity 25,000 +1.1%
Value US$100,655
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.30
Quantity 10,000 +0.4%
Value US$42,968
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.36
Quantity 10,000 +0.4%
Value US$43,601
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.31
Quantity 10,000 +0.4%
Value US$43,107
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.21
Quantity 10,000 +0.4%
Value US$42,071
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 35,000 +1.6%
Value US$140,000
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.56
Quantity 35,000 +1.6%
Value US$159,750
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 12,500 +0.8%
Value US$175,000
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.01
Quantity 360,000,000 +516.1%
Value US$3,492,000
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.01
Quantity 360,000,000 +516.1%
Value US$3,492,000
Banon Sid Former Director
Transaction date
Sale
Price
0.02
Quantity 586,222 -90.8%
Value US$11,724
CHAZEN JEROME A Non-Executive Director
Transaction date
Sale
Price
0.02
Quantity 2,344,887 -90.8%
Value US$46,898
KIER ISAAC Non-Executive Director
Transaction date
Sale
Price
0.02
Quantity 17,586,652 -90.8%
Value US$351,733
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-11 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF

Executive Director
37,237 -19.0%
311.96
US$3,601,909 		37,237 -19.0% 311.96 US$3,601,909
2026-08-10 2026-08-06 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF

Executive Director
79,313 -45.3%
431.66
US$2,835,837 		79,313 -45.3% 431.66 US$2,835,837
2026-08-06 2026-08-05 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF

Executive Director
28,606 -15.3%
448.41
US$1,515,293 		28,606 -15.3% 448.41 US$1,515,293
2026-08-03 2026-07-30 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF.

Executive Director
1,000 +inf%
0.18
US$100,000 		1,000 +inf% 0.18 US$100,000
2023-10-13 2023-10-12 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
8,000 +21.2%
0.81
US$6,480 		8,000 +21.2% 0.81 US$6,480
2022-05-18 2022-05-18 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
8,000 +5.6%
0.72
US$5,760 		8,000 +5.6% 0.72 US$5,760
2022-05-18 2022-05-17 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
23,000 +19.1%
0.71
US$16,330 		23,000 +19.1% 0.71 US$16,330
2021-05-03 2021-04-30 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
1,000 +0.8%
2.29
US$2,290 		1,000 +0.8% 2.29 US$2,290
2021-05-03 2021-04-29 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
1,000 +0.8%
2.29
US$2,290 		1,000 +0.8% 2.29 US$2,290
2016-08-18 2016-06-17 B Purchase ARMEN GARO H

See Remarks

Executive Director Large shareholder
60,211 +1.4%
1.25
US$75,264 		60,211 +1.4% 1.25 US$75,264
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
1,758 +0.4%
2.09
US$3,674 		1,758 +0.4% 2.09 US$3,674
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
300 +0.1%
2.08
US$624 		300 +0.1% 2.08 US$624
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
569 +0.1%
2.07
US$1,178 		569 +0.1% 2.07 US$1,178
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
74 +0.0%
2.00
US$148 		74 +0.0% 2.00 US$148
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
1,334 +0.3%
1.99
US$2,655 		1,334 +0.3% 1.99 US$2,655
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
900 +0.2%
1.98
US$1,782 		900 +0.2% 1.98 US$1,782
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
266 +0.1%
1.97
US$524 		266 +0.1% 1.97 US$524
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
5,000 +1.1%
1.90
US$9,500 		5,000 +1.1% 1.90 US$9,500
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
3,499 +0.8%
1.79
US$6,263 		3,499 +0.8% 1.79 US$6,263
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
100 +0.0%
1.70
US$170 		100 +0.0% 1.70 US$170
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
100 +0.0%
1.64
US$164 		100 +0.0% 1.64 US$164
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
600 +0.1%
1.63
US$978 		600 +0.1% 1.63 US$978
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
300 +0.1%
1.60
US$480 		300 +0.1% 1.60 US$480
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
200 +0.0%
1.59
US$318 		200 +0.0% 1.59 US$318
2010-01-07 2009-12-21 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
5,376 +0.2%
0.60
US$3,226 		5,376 +0.2% 0.60 US$3,226
2010-01-07 2009-12-14 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
527,683 +20.4%
0.65
US$342,888 		527,683 +20.4% 0.65 US$342,888
2010-01-07 2009-12-09 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
21,947 +0.9%
0.67
US$14,704 		21,947 +0.9% 0.67 US$14,704
2010-01-07 2009-12-08 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
86,386 +3.5%
0.66
US$56,989 		86,386 +3.5% 0.66 US$56,989
2010-01-07 2009-11-19 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
25,000 +1.0%
0.85
US$21,250 		25,000 +1.0% 0.85 US$21,250
2010-01-07 2009-11-16 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
50,500 +2.1%
0.85
US$42,925 		50,500 +2.1% 0.85 US$42,925
2010-01-07 2009-11-13 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
50,000 +2.1%
0.86
US$42,920 		50,000 +2.1% 0.86 US$42,920
2010-01-07 2009-11-12 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
11,100 +0.5%
0.85
US$9,435 		11,100 +0.5% 0.85 US$9,435
2008-11-26 2008-11-25 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
25,000 +1.1%
1.17
US$29,290 		25,000 +1.1% 1.17 US$29,290
2008-09-03 2008-08-29 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
25,000 +1.1%
4.03
US$100,655 		25,000 +1.1% 4.03 US$100,655
2008-06-17 2008-06-13 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.30
US$42,968 		10,000 +0.4% 4.30 US$42,968
2008-06-12 2008-06-11 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.36
US$43,601 		10,000 +0.4% 4.36 US$43,601
2008-06-12 2008-06-10 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.31
US$43,107 		10,000 +0.4% 4.31 US$43,107
2008-06-09 2008-06-05 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.21
US$42,071 		10,000 +0.4% 4.21 US$42,071
2008-06-02 2008-06-02 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
35,000 +1.6%
4.00
US$140,000 		35,000 +1.6% 4.00 US$140,000
2008-06-02 2008-05-30 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
35,000 +1.6%
4.56
US$159,750 		35,000 +1.6% 4.56 US$159,750
2007-12-03 2007-11-30 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
12,500 +0.8%
14.00
US$175,000 		12,500 +0.8% 14.00 US$175,000
2007-03-06 2007-02-12 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
360,000,000 +516.1%
0.01
US$3,492,000 		360,000,000 +516.1% 0.01 US$3,492,000
2007-03-06 2007-02-12 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
360,000,000 +516.1%
0.01
US$3,492,000 		360,000,000 +516.1% 0.01 US$3,492,000
2006-10-27 2006-10-24 S Sale Banon Sid

Former Director
586,222 -90.8%
0.02
US$11,724 		586,222 -90.8% 0.02 US$11,724
2006-10-27 2006-10-24 S Sale CHAZEN JEROME A Non-Executive Director
2,344,887 -90.8%
0.02
US$46,898 		2,344,887 -90.8% 0.02 US$46,898
2006-10-26 2006-10-24 S Sale KIER ISAAC Non-Executive Director
17,586,652 -90.8%
0.02
US$351,733 		17,586,652 -90.8% 0.02 US$351,733
Explore more

More insider trading research around Protagenic Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America